Alkahest Revenue and Competitors
Estimated Revenue & Valuation
- Alkahest's estimated annual revenue is currently $12.2M per year.
- Alkahest's estimated revenue per employee is $155,000
Employee Data
- Alkahest has 79 Employees.
- Alkahest grew their employee count by -26% last year.
Alkahest's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Sr. VP Informatics | Reveal Email/Phone |
2 | Controller | Reveal Email/Phone |
3 | Head Information Technology | Reveal Email/Phone |
4 | SVP | Reveal Email/Phone |
5 | Chief Business Officer | Reveal Email/Phone |
6 | Director, Clinical Data Management | Reveal Email/Phone |
7 | Director, Transcriptomics | Reveal Email/Phone |
8 | Senior Medical Director | Reveal Email/Phone |
9 | Director, Software Engineering and Data Architecture | Reveal Email/Phone |
10 | Director Facilities | Reveal Email/Phone |
Alkahest Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $72.3M | 438 | 7% | $564M | $10.2B |
What Is Alkahest?
Alkahest is developing therapies derived from blood to treat neurological diseases, with an emphasis on age-related cognitive decline -- key medical challenges of our generation. The company's breakthrough research has demonstrated that factors in blood plasma of young mice are able to reverse brain deficits in normal aging and Alzheimer's disease models in mice. Clinical studies are being conducted in patients with different types of dementia and other neurodegenerative diseases. Alkahest is a private company based in San Carlos, CA, with investors including Barcelona, Spain-based Grifols, a global healthcare company and leading producer of plasma therapies, also a collaboration and commercialization partner.
keywords:N/A
N/A
Total Funding
79
Number of Employees
$12.2M
Revenue (est)
-26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Alkahest News
In a randomized clinical study by the company, Alkahest, 39 patients intravenously received either 100 milliliters or 250 milliliters of the plasma ...
Alkahest's experimental blood-derived protein GRF6019 helps maintain cognition and function in mild to moderate Alzheimer's disease ...
SAN CARLOS, Calif., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical stage biotechnology company focused on developing ...
SAN CARLOS, Calif. — The executives at Alkahest have heard plenty of vampire jokes. They are, after all, turning to blood from young donors in search of an elixir for diseases associated with aging. And yes, they’re in Silicon Valley. But this five-year-old biotech company led by Genentech alum ...
Other Companies in San Carlos
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12.2M | 79 | 32% | N/A |
#2 | $12.6M | 81 | 19% | $156M |
#3 | $18M | 82 | 0% | N/A |
#4 | $24.8M | 92 | -2% | N/A |
#5 | $21.4M | 102 | 2% | N/A |